BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 18519675)

  • 1. Genome-wide copy number analysis in esophageal adenocarcinoma using high-density single-nucleotide polymorphism arrays.
    Nancarrow DJ; Handoko HY; Smithers BM; Gotley DC; Drew PA; Watson DI; Clouston AD; Hayward NK; Whiteman DC
    Cancer Res; 2008 Jun; 68(11):4163-72. PubMed ID: 18519675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mapping of homozygous deletions in verified esophageal adenocarcinoma cell lines and xenografts.
    Boonstra JJ; van Marion R; Douben HJ; Lanchbury JS; Timms KM; Abkevich V; Tilanus HW; de Klein A; Dinjens WN
    Genes Chromosomes Cancer; 2012 Mar; 51(3):272-82. PubMed ID: 22081516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-wide catalogue of chromosomal aberrations in barrett's esophagus and esophageal adenocarcinoma: a high-density single nucleotide polymorphism array analysis.
    Gu J; Ajani JA; Hawk ET; Ye Y; Lee JH; Bhutani MS; Hofstetter WL; Swisher SG; Wang KK; Wu X
    Cancer Prev Res (Phila); 2010 Sep; 3(9):1176-86. PubMed ID: 20651033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromosomal abnormalities and novel disease-related regions in progression from Barrett's esophagus to esophageal adenocarcinoma.
    Akagi T; Ito T; Kato M; Jin Z; Cheng Y; Kan T; Yamamoto G; Olaru A; Kawamata N; Boult J; Soukiasian HJ; Miller CW; Ogawa S; Meltzer SJ; Koeffler HP
    Int J Cancer; 2009 Nov; 125(10):2349-59. PubMed ID: 19670330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide loss of heterozygosity and copy number analysis in melanoma using high-density single-nucleotide polymorphism arrays.
    Stark M; Hayward N
    Cancer Res; 2007 Mar; 67(6):2632-42. PubMed ID: 17363583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are there any more ovarian tumor suppressor genes? A new perspective using ultra high-resolution copy number and loss of heterozygosity analysis.
    Gorringe KL; Ramakrishna M; Williams LH; Sridhar A; Boyle SE; Bearfoot JL; Li J; Anglesio MS; Campbell IG
    Genes Chromosomes Cancer; 2009 Oct; 48(10):931-42. PubMed ID: 19603523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-wide analysis of genetic alterations in Barrett's adenocarcinoma using single nucleotide polymorphism arrays.
    Wiech T; Nikolopoulos E; Weis R; Langer R; Bartholomé K; Timmer J; Walch AK; Höfler H; Werner M
    Lab Invest; 2009 Apr; 89(4):385-97. PubMed ID: 18663352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome wide analysis of DNA copy number neutral loss of heterozygosity (CNNLOH) and its relation to gene expression in esophageal squamous cell carcinoma.
    Hu N; Clifford RJ; Yang HH; Wang C; Goldstein AM; Ding T; Taylor PR; Lee MP
    BMC Genomics; 2010 Oct; 11():576. PubMed ID: 20955586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-wide analysis of esophageal adenocarcinoma yields specific copy number aberrations that correlate with prognosis.
    Frankel A; Armour N; Nancarrow D; Krause L; Hayward N; Lampe G; Smithers BM; Barbour A
    Genes Chromosomes Cancer; 2014 Apr; 53(4):324-38. PubMed ID: 24446147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequent occurrence of uniparental disomy in colorectal cancer.
    Andersen CL; Wiuf C; Kruhøffer M; Korsgaard M; Laurberg S; Ørntoft TF
    Carcinogenesis; 2007 Jan; 28(1):38-48. PubMed ID: 16774939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-wide profiling of chromosomal alterations in renal cell carcinoma using high-density single nucleotide polymorphism arrays.
    Chen M; Ye Y; Yang H; Tamboli P; Matin S; Tannir NM; Wood CG; Gu J; Wu X
    Int J Cancer; 2009 Nov; 125(10):2342-8. PubMed ID: 19521957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-wide loss of heterozygosity and copy number alteration in esophageal squamous cell carcinoma using the Affymetrix GeneChip Mapping 10 K array.
    Hu N; Wang C; Hu Y; Yang HH; Kong LH; Lu N; Su H; Wang QH; Goldstein AM; Buetow KH; Emmert-Buck MR; Taylor PR; Lee MP
    BMC Genomics; 2006 Nov; 7():299. PubMed ID: 17134496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative genomics of esophageal adenocarcinoma and squamous cell carcinoma.
    Bandla S; Pennathur A; Luketich JD; Beer DG; Lin L; Bass AJ; Godfrey TE; Litle VR
    Ann Thorac Surg; 2012 Apr; 93(4):1101-6. PubMed ID: 22450065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allelotype analysis of oesophageal adenocarcinoma: loss of heterozygosity occurs at multiple sites.
    Dolan K; Garde J; Gosney J; Sissons M; Wright T; Kingsnorth AN; Walker SJ; Sutton R; Meltzer SJ; Field JK
    Br J Cancer; 1998 Oct; 78(7):950-7. PubMed ID: 9764589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative genomic hybridization of esophageal adenocarcinoma and squamous cell carcinoma cell lines.
    Su M; Chin SF; Li XY; Edwards P; Caldas C; Fitzgerald RC
    Dis Esophagus; 2006; 19(1):10-4. PubMed ID: 16364037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analyzing the profile of chromosomal imbalances in esophageal atypical hyperplasia and early stage esophageal squamous cell carcinoma by 250K Snp Array].
    Zhang X; Zhu ZH; Lin P; Yang H; Fu JH; Zhang LJ; Long H; Wen J; Huang XP; Fang Y; Rong TH
    Zhonghua Yi Xue Za Zhi; 2008 Oct; 88(37):2636-41. PubMed ID: 19080713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Copy number neutral loss of heterozygosity at 17p and homozygous mutations of TP53 are associated with complex chromosomal aberrations in patients newly diagnosed with myelodysplastic syndromes.
    Svobodova K; Zemanova Z; Lhotska H; Novakova M; Podskalska L; Belickova M; Brezinova J; Sarova I; Izakova S; Lizcova L; Berkova A; Siskova M; Jonasova A; Cermak J; Michalova K
    Leuk Res; 2016 Mar; 42():7-12. PubMed ID: 26851439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-resolution array copy number analyses for detection of deletion, gain, amplification and copy-neutral LOH in primary neuroblastoma tumors: four cases of homozygous deletions of the CDKN2A gene.
    Carén H; Erichsen J; Olsson L; Enerbäck C; Sjöberg RM; Abrahamsson J; Kogner P; Martinsson T
    BMC Genomics; 2008 Jul; 9():353. PubMed ID: 18664255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NSAIDs modulate CDKN2A, TP53, and DNA content risk for progression to esophageal adenocarcinoma.
    Galipeau PC; Li X; Blount PL; Maley CC; Sanchez CA; Odze RD; Ayub K; Rabinovitch PS; Vaughan TL; Reid BJ
    PLoS Med; 2007 Feb; 4(2):e67. PubMed ID: 17326708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex changes and multiple forms of chromosomal instability in colorectal cancers.
    Gaasenbeek M; Howarth K; Rowan AJ; Gorman PA; Jones A; Chaplin T; Liu Y; Bicknell D; Davison EJ; Fiegler H; Carter NP; Roylance RR; Tomlinson IP
    Cancer Res; 2006 Apr; 66(7):3471-9. PubMed ID: 16585170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.